Physician profile
Audrey M Eckerle
NPI 1538318290
$237.32
in general payments reported to CMS, 2019-2025
8 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $31.25 · 2022: $34.29 · 2023: $18.58 · 2024: $30.10 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $155 · Education: $16.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $155.45 |
| Education | $16.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $69.92 | 2025 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $54.82 | 2022-2025 | |
| Otsuka America Pharmaceutical, INC. | $33.83 | 2021-2023 | Jynarque |
| Lilly USA, LLC | $16.72 | 2025 | Jardiance |
| Calliditas Therapeutics US INC. | $16.46 | 2022 | |
| Opko Pharmaceuticals, LLC | $16.33 | 2025 | Rayaldee |
| Vifor Pharma, INC. | $16.00 | 2021 | |
| Fresenius USA Marketing, INC. | $13.24 | 2024 | Velphoro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Audrey Eckerle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.